Sign in to view content

The OASIS Trial: Natural History of Symptomatic Vitreomacular Adhesion

Joseph M. Coney, MD, FASRS

Video
Published 2016

Related

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021
Survey of Patient Utilization of Web-Based Health Data Management Technology in an Outpatient Ophthalmology Practice Setting
Annual Meeting Talks
2016
Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD
Szilárd Kiss, MD
Annual Meeting Talks
2016

Category: Vitreomacular Traction

See more